Literature DB >> 7685427

The prevalence of prostatism: a population-based survey of urinary symptoms.

C G Chute1, L A Panser, C J Girman, J E Oesterling, H A Guess, S J Jacobsen, M M Lieber.   

Abstract

To establish the age-specific prevalence of urinary symptoms among a community-based cohort of men, a randomly selected sample of men were screened and invited to participate in a longitudinal survey of urinary symptoms. The population of Olmsted County, Minnesota, as enumerated by the Rochester Epidemiology Project, formed the sampling base for this study. Men between 40 and 79 years old with no history of prostate or other urological surgery, and who also were free of conditions associated with neurogenic bladder were invited to participate. A previously validated questionnaire was completed by the subject. Urine flow measures, current medications and family histories of urinary disease were also obtained. Nonresponse corrected scores for a composite of obstructive symptoms showed moderate to severe symptomatology among 13% of the men 40 to 49 years old and 28% of those older than 70 years. Prostatism is a highly prevalent symptom complex among unselected men in the community. The specific urinary symptoms of nocturia, weak stream, restarting, urgency and sensation of incomplete emptying are strongly age-related and, therefore, may be predictive of a prostatic disease process.

Entities:  

Mesh:

Year:  1993        PMID: 7685427     DOI: 10.1016/s0022-5347(17)35405-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  144 in total

1.  The competing effects of disease states on quality of life of the elderly: the case of urinary symptoms in men.

Authors:  B Mozes; Y Maor; A Shmueli
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

Review 2.  Female nocturia.

Authors:  Gitte M Hvistendahl; Jens C Djurhuus
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

3.  The aging male population and medical care for benign prostatic hyperplasia in Canada.

Authors:  Nigel S B Rawson; Fred Saad
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

Review 4.  Combination therapy for the pharmacological management of benign prostatic hyperplasia: rationale and treatment options.

Authors:  Jaspreet S Sandhu; E Darracott Vaughan
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Update on the american urological association guidelines for the treatment of benign prostatic hyperplasia.

Authors:  Steven A Kaplan
Journal:  Rev Urol       Date:  2006

6.  Is nighttime voiding normal or anomalous?

Authors:  M O'leary; M B Chancellor
Journal:  Rev Urol       Date:  2001

7.  Selecting candidates for radical prostatectomy.

Authors:  H Lepor
Journal:  Rev Urol       Date:  2000

Review 8.  Predictive medicine in non-malignant urological disorders.

Authors:  Mariangela Mancini; Antonio Cisternino; Ivan Matteo Tavolini; Fabrizio Dal Moro; Pierfrancesco Bassi
Journal:  World J Urol       Date:  2003-12-20       Impact factor: 4.226

9.  Shared care between general practitioners and urologists in the management of benign prostatic hyperplasia: a survey of attitudes among clinicians.

Authors:  R S Kirby; G Chisholm; C Chapple; C Hudd; M Swallow; D Shore
Journal:  J R Soc Med       Date:  1995-05       Impact factor: 5.344

10.  The potential for NX-1207 in benign prostatic hyperplasia: an update for clinicians.

Authors:  Neal Shore; Barrett Cowan
Journal:  Ther Adv Chronic Dis       Date:  2011-11       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.